Johnson & Johnson news

   Watch this stock
Showing stories 11 - 20 of about 118   

Articles published

JNJ 103.13 +0.50 (0.49%)
price chart
Johnson & Johnson accelerates Ebola vaccine testing amid heightened anxiety
"We are urgently working to provide our vaccine expertise, production capabilities, our people and resources to address the Ebola crisis," said Alex Gorsky, Chairman and CEO of Johnson & Johnson." Our innovation model enables us to quickly mobilize our ...
Related articles »  
J&J sales top forecast, helped by drug for hep C
At the end of September, Johnson & Johnson announced plans to buy Alios BioPharma, a biotech company focused on developing existing therapies for viral diseases.
Business Day|Johnson & Johnson Raises 2014 Earnings Forecast Again  New York Times
Why I'm in Johnson & Johnson for the long run  The Globe and Mail
Related articles »  
One Put, One Call Option To Know About for Johnson & Johnson
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson JNJ +0.49% (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract ...
Related articles »  
The Biggest Threat Facing Johnson & Johnson
Johnson & Johnson (NYSE: JNJ ) is one of the globe's biggest healthcare companies. Its businesses include everything from Band-Aids to catheters, to cancer busting compounds.
Johnson & Johnson's Growth Potential Is Stronger Than You Think (JNJ)  Seeking Alpha (registration)
Related articles »  
Company News: McDonald's, Coca-Cola, Target, Johnson & Johnson, Amazon ...
Johnson & Johnson (JNJ) said it would begin testing a vaccine for the Ebola virus in humans in January. So far, the treatment has proved effective in monkeys.
Related articles »  
Johnson & Johnson Earnings Preview: Pharma Is Where The Party Is
This year has been eventful for Johnson & Johnson. The company completed the divestiture of Ortho-Clinical Diagnostics to Carlyle Group in Q3 2014 and got the approval for its new blockbuster drug Olysio in Europe in the second quarter.
Related articles »  
Johnson & Johnson fuel Knights' playoffs quest
GAINESVILLE - The Johnson & Johnson trademark usually means a company geared to healing and pain-reduction, but in local football circles, the names Johnson and Johnson - namely Jordan Johnson and Marcus Johnson - have become synonymous ...
Johnson & Johnson Takes Aim at Gilead Sciences, inc.
Johnson & Johnson (NYSE: JNJ ) doesn't typically like to play second fiddle to anyone, particularly when billions of dollars in drug sales are at stake.
Related articles »  
Why Johnson & Johnson (JNJ) Stock Is Climbing Today
Johnson & Johnson is one of the biggest health care companies in the world, and has interests in pharmaceuticals, medical devices, and consumer diagnostics with It's s a number of well known brands in its product portfolio including Johnson's baby ...
What to expect from Johnson & Johnson's earnings
Johnson & Johnson, the shares of which have been among the better year-to-date performers of components of the Dow Jones Industrial Average, is scheduled to report third-quarter results ahead of Tuesday's open.